SCHEMBL229947

SCHEMBL229947

CC1(C)CCCC2=C1CC(C=O)CC2

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.45
▸ ALDH1A1 P00352 3/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ MCL1 Q07820 3/20 0.38
▸ NPSR1 Q6W5P4 2/20 0.38
▸ GAA P10253 1/20 0.38
▸ ALOX12 P18054 1/20 0.38
▸ AGTR1 P30556 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ SLC2A1 P11166 1/20 0.36
▸ LMNA P02545 2/20 0.33
▸ HPGD P15428 1/20 0.33
▸ CCR6 P51684 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15199501 0.86 POLB (0.45) POLBALDH1A1TDP1MCL1NPSR1
SCHEMBL3506598 0.70 POLB (0.41) POLBALDH1A1TDP1MCL1NPSR1
SCHEMBL23832183 0.70 — —
SCHEMBL6225801 0.69 MCL1 (0.40) POLBALDH1A1TDP1MCL1NPSR1
SCHEMBL5947574 0.69 — —
SCHEMBL7680587 0.69 — —
SCHEMBL2123286 0.68 POLB (0.33) POLBALDH1A1TDP1
SCHEMBL31675176 0.67 POLB (0.56) POLBALDH1A1TDP1MCL1NPSR1
SCHEMBL869519 0.67 POLB (0.56) POLBALDH1A1TDP1MCL1NPSR1
SCHEMBL10316754 0.67 POLB (0.41) POLBALDH1A1TDP1MCL1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1383 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12589377-B2 Encapsulated composition comprising core-shell microcapsules and process for its preparation GIVAUDAN SA (CH) 2026-03-31 — — US claimed
EP-4655373-A1 BIODEGRADABLE PERFUME COMPOSITION Givaudan SA (CH) 2025-12-03 — — EP claimed
US-20250325463-A1 COMPOSITIONS (III) SYMRISE AG (DE) 2025-10-23 — — US claimed
US-12398341-B2 Apparatus and compositions for improving scent delivery THE PROCTER & GAMBLE COMPANY (US) 2025-08-26 — — US claimed
CN-119968452-A Perfume mixture (VI) 西姆莱斯股份公司 2025-05-09 — — CN claimed
EP-4532646-A1 A FRAGRANCE MIXTURE (V) Symrise AG (DE) 2025-04-09 — — EP claimed
CN-119790128-A Perfume mixture (III) 西姆莱斯股份公司 2025-04-08 — — CN claimed
US-20250099349-A1 A FRAGRANCE MIXTURE SYMRISE AG (DE) 2025-03-27 — — US claimed
WO-2025051371-A1 A FRAGRANCE PASTILLE SYMRISE AG (DE) 2025-03-13 — — WO claimed
US-12247180-B2 Apparatus and compositions for improving scent delivery THE PROCTER & GAMBLE COMPANY (US) 2025-03-11 — — US claimed
EP-1848702-A2 PRO-FRAGRANCE AND PRO-FLAVORANT COMPOSITIONS Flexitral, Inc. (US) 2007-10-31 — — EP claimed
US-20070185228-A1 Fragranced polymer with malodor counteractant PNC BANK, NATIONAL ASSOCIATION 2007-08-09 — — US claimed
WO-2007061823-A1 FRAGRANCED POLYMER WITH MALODOR COUNTERACTANT ROBERTET FRAGRANCES, INC. (US) 2007-05-31 — — WO claimed
CN-1969033-A Perfumed liquid laundry detergent composition comprising a functionalized silicone fabric care agent PROCTER & GAMBLE (US) 2007-05-23 — — CN claimed
CN-1942573-A Liquid laundry detergent compositions comprising silicone blends as fabric care agents PROCTER & GAMBLE (US) 2007-04-04 — — CN claimed
US-20060205632-A1 Pro-fragrance and pro-flavorant compositions FLEXITRAL, INC. 2006-09-14 — — US claimed
WO-2006085048-A2 PRO-FRAGRANCE AND PRO-FLAVORANT COMPOSITIONS FLEXITRAL, INC. (US) 2006-08-17 — — WO claimed
WO-2005079573-A1 ANTIFUNGAL COMPOSITIONS GIVAUDAN SA (CH) 2005-09-01 — — WO claimed
EP-0980863-A1 Oxime carboxylic acid derivatives Givaudan Roure (International) S.A. (CH) 2000-02-23 — — EP claimed
US-5795566-A Deodorant compositions containing at least two aldehydes and the deodorant products containing them ROBERTET S.A. (FR) 1998-08-18 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12589377-B2 Encapsulated composition comprising core-shell microcapsules and process for its preparation CUTA, EXOC1, EXOSC10 POLB 2351/4885ALDH1A1 2581/4885TDP1 1746/4885
US-20250099349-A1 A FRAGRANCE MIXTURE PTMS, EP300, TRPA1 POLB 2188/4885ALDH1A1 967/4885TDP1 3045/4885
US-20060205632-A1 Pro-fragrance and pro-flavorant compositions TAS2R10, TAS2R9, OR10J3 POLB 1650/4885ALDH1A1 1201/4885TDP1 4718/4885
US-20250325463-A1 COMPOSITIONS (III) NISCH, TAS1R3, TAS2R3 POLB 441/4885ALDH1A1 1377/4885TDP1 4022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback